Bernstein: 'We Anticipate Abbvie (ABBV) To Be Down MSD Today'

February 5, 2026 7:36 AM EST Send to a Friend
Bernstein SocGen Group analyst Courtney Breen reiterated a Market Perform rating and $225.00 price target on Abbvie (NYSE: ABBV).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login